Clinical Trial

Herombopag Treated T-DM1 Induced Platelet Reduction

Name: Herombopag Treated T-DM1 Induced Platelet Reduction — clinical trial record (NCT07257809)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a single-arm study planned to enroll 56 breast cancer patients who experienced grade 2 or higher thrombocytopenia following prior chemotherapy and achieved normalization (platelet count ≥100 × 109/L and ≥200 × 109/L) through intervention.

Trial Details

NCT Number	NCT07257809
Lead Sponsor	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions	Thrombocytopenia
Enrollment	56 participants
Start Date	2025-10-13
Primary Completion	2026-09-26 (estimated)
Study Completion	2027-09-26 (estimated)
Updated on ClinicalTrials.gov	2025-12-02